SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1259Piper: NBIX :Additional Details From Biocentury Presentation 2004-09-10 04:35 (mopgcw-9/15/2004
1258Piper: NBIX :Positive Elderly MR Phase III Data – NDA Filing On Track mopgcw-9/15/2004
1257La Jolla Institute for Molecular Medicine Scientists Discover New Link Between Snigel bates-9/10/2004
1256I couldn't find anything in their release to justify the weakness. Anyone Biomaven-9/9/2004
1255Quid for Pres. (eom)scaram(o)uche-9/9/2004
1254OT on US Media Reportage of Terrorism, Iraq, etc.: On my butt. MRI this past Tuquidditch-9/9/2004
1253Hey, you on your feet or on your back?? Shoulder? (eom)scaram(o)uche-9/9/2004
1252I guess it was the "Neurocrine is on track to submit its two New Drug Appliquidditch-9/9/2004
1251Neurocrine Reports Positive Phase III Efficacy and Safety Results With Indiplon scaram(o)uche-9/9/2004
1250Neurocrine Biosciences moves to Carmel Valley By: BRADLEY J. FIKES - Staff WritIcebrg-9/1/2004
1249MITCHELL W THOMAS,Director,BUYS 1,000 ON 8/9/04 OF NBIX 2004-08-10 18:58 (New Yomopgcw-8/11/2004
1248Thanks quid, There were a couple other exchanges that made it seem some have thkeokalani'nui-8/2/2004
1247Pdufa date and approval: At about 39 minutes through the cc, there was an intenquidditch-8/1/2004
1246That's great news, thank you.keokalani'nui-7/30/2004
1245No, neither one is the compound NBIX ran through Phase I previously. That'sNeuroInvestment-7/29/2004
1244Re: CRF >>A compound has been selected to begin Phase I clinical trials bkeokalani'nui-7/29/2004
1243Aww Harry, what did you go do that for, the HFs were giving us the opportunity tmopgcw-7/15/2004
1242I had spoken to NBIX recently about a clear shorting campaign that I had witnessNeuroInvestment-7/15/2004
1241chuckle. the timing is also interesting given the weakness in the stock...if i mopgcw-7/15/2004
1240George, the references to "the alliance...the alliance...the alliance."quidditch-7/15/2004
1239Neurocrine Reports Progress on Indiplon Registration Thursday July 15, 7:00 am mopgcw-7/15/2004
1238SSB: Neurocrine Biosciences (NBIX, Hold, Speculative) Reporting date: Tentativmopgcw-7/9/2004
1237The state of GPCR research in 2004 The Nature Reviews Drug Discovery GPCR QuestiIcebrg-7/7/2004
1236Neurocrine Biosciences initiated with "hold" Tuesday, June 29, 2004 9Icebrg-6/29/2004
1235Sanofi has filed for US approval to market Ambien CR. Message 20255998Icebrg-6/26/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News